Finance

Lists
ROVI:BME
Laboratorios Farmaceuticos ROVI SA
€69.20
-1.35%
(-0.95) 1D
Nov 13, 5:36:00 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ROVI...
Open
€70.00
High
€70.15
Low
€68.90
Mkt. cap
3.55B
Avg. vol.
117.82K
Volume
88.92K
Dividend
1.39%
Quarterly dividend
€0.24
Ex-dividend date
Jul 13, 2026
P/E ratio
17.07
52-wk high
€86.70
52-wk low
€53.10
EPS
€4.05
Shares outstanding
51.24M
No. of employees
2K
Open
€70.00
High
€70.15
Low
€68.90
Mkt. cap
3.55B
Avg. vol.
117.82K
Volume
88.92K
Dividend
1.39%
Quarterly dividend
€0.24
Ex-dividend date
Jul 13, 2026
P/E ratio
17.07
52-wk high
€86.70
52-wk low
€53.10
EPS
€4.05
Shares outstanding
51.24M
No. of employees
2K
News stories
From web sources and news partners
Profile
Laboratorios Farmaceuticos Rovi SA is a Spanish pharmaceutical company. The company is a member of the IBEX 35 stock market index. Wikipedia
About Laboratorios Farmaceuticos ROVI SA
CEO-
Employees2.47K
Founded1946
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiterovi.es
Last report
Nov 5, 2026
Fiscal period
Q3 2026
€1.52 / -
0.00%miss
Revenue / Est. (EUR)
610.17M / 234.06M
+160.69%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
218.42M
152.49M
191.67M
266.01M
Cost of goods sold
90.33M
59.61M
60.04M
69.77M
Cost of revenue
90.33M
59.61M
60.04M
69.77M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55.40M
38.04M
47.22M
44.43M
Operating expense
73.16M
83.00M
113.58M
111.50M
Total operating expenses
163.49M
142.61M
173.62M
181.27M
Operating income
54.93M
9.89M
18.05M
84.74M
Other non operating income
3.80M
2.32M
10.64M
10.72M
EBT including unusual items
57.94M
12.29M
89.28M
95.26M
EBT excluding unusual items
57.94M
12.29M
26.93M
95.26M
Income tax expense
15.29M
2.84M
14.35M
16.86M
Effective tax rate
26.39%
23.11%
16.07%
17.70%
Other operating expenses
9.61M
36.79M
56.55M
57.15M
Net income
42.68M
9.48M
75.00M
78.42M
Net profit margin
19.54%
6.22%
39.13%
29.48%
Earnings per share
-
-
-
-
Interest and investment income
-
403.00K
474.00K
323.00K
Interest expense
-767.00K
-782.00K
-1.97M
-626.00K
Net interest expenses
-767.00K
-379.00K
-1.50M
-303.00K
Depreciation and amortization charges
8.16M
8.17M
9.81M
9.91M
EBITDA
55.10M
18.05M
23.60M
98.91M
Gain or loss from assets sale
14.00K
1.77M
-2.00K
-
Upcoming events
AI content may include mistakes. Learn more
Google apps